105 related articles for article (PubMed ID: 24424752)
1. Sex chromosome loss may represent a disease-associated clonal population in chronic lymphocytic leukemia.
Chapiro E; Antony-Debre I; Marchay N; Parizot C; Lesty C; Cung HA; Mathis S; Grelier A; Maloum K; Choquet S; Azgui Z; Uzunov M; Leblond V; Merle-Beral H; Sutton L; Davi F; Nguyen-Khac F
Genes Chromosomes Cancer; 2014 Mar; 53(3):240-7. PubMed ID: 24424752
[TBL] [Abstract][Full Text] [Related]
2. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
3. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
4. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW
Cancer Genet Cytogenet; 2006 Apr; 166(2):152-6. PubMed ID: 16631472
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
8. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
10. [A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies].
Struski S; Leymarie V; Helias C; Falkenrodt A; Fohrer C; Audhuy B; Lioure B; Moskovtchenko P; Mazurier I; Galoisy AC; Gervais C; Mauvieux L; Herbrecht R; Bergerat JP; Lessard M
Pathol Biol (Paris); 2007 Feb; 55(1):59-72. PubMed ID: 16690228
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
Reddy KS
Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
[TBL] [Abstract][Full Text] [Related]
14. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
Puiggros A; Delgado J; Rodriguez-Vicente A; Collado R; Aventín A; Luño E; Grau J; Hernandez JÁ; Marugán I; Ardanaz M; González T; Valiente A; Osma M; Calasanz MJ; Sanzo C; Carrió A; Ortega M; Santacruz R; Abrisqueta P; Abella E; Bosch F; Carbonell F; Solé F; Hernández JM; Espinet B;
Br J Haematol; 2013 Oct; 163(1):47-54. PubMed ID: 23869550
[TBL] [Abstract][Full Text] [Related]
15. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
[TBL] [Abstract][Full Text] [Related]
16. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
[TBL] [Abstract][Full Text] [Related]
18. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
19. Preimplantation genetic screening (PGS) in infertile female age > or = 35 years by fluorescence in situ hybridization of chromosome 13, 18, 21, X and Y.
Chiamchanya C; Visutakul P; Gumnarai N; Su-angkawatin W
J Med Assoc Thai; 2008 Nov; 91(11):1644-50. PubMed ID: 19127783
[TBL] [Abstract][Full Text] [Related]
20. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
Sánchez J; Aventín A
Cancer Genet Cytogenet; 2007 May; 175(1):57-60. PubMed ID: 17498559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
